Neurology Thesis Topics

Neurology Thesis Topics

This page brings together neurology thesis topics and neurological disease research topics suitable for MD/DNB Medicine residents, covering acute ischaemic stroke, intracerebral haemorrhage, seizures and epilepsy, central nervous system infections, headache disorders, movement disorders, peripheral neuropathy, neuromuscular disease, cognitive disorders and neurological manifestations of systemic illness. Most designs can be completed within one thesis period using patients, bedside neurological assessment, routine laboratory investigations, electroencephalography, neuroimaging and follow-up already available in teaching hospitals. Before registration, the selected question should be converted into a department-specific MD Medicine neurology protocol and MD Medicine neurology synopsis.

Last reviewed and updated: September 2026 · 2026–27 admissions

Our MD Medicine Thesis Guidance provides structured protocols, sample size formulas, and institutional review board (IRB) layout guides.

Acute Ischaemic Stroke

  1. National Institutes of Health Stroke Scale score in adults with acute ischaemic stroke compared across infarct locations for predicting functional status at discharge: a prospective observational study
  2. Admission blood glucose in adults with acute ischaemic stroke compared across National Institutes of Health Stroke Scale categories for predicting in-hospital mortality: a prospective observational study
  3. Glycated haemoglobin in adults with acute ischaemic stroke and diabetes mellitus compared across neurological severity categories for predicting functional outcome at three months: a prospective observational study
  4. Neutrophil to lymphocyte ratio in adults with acute ischaemic stroke compared across National Institutes of Health Stroke Scale categories for predicting functional outcome at discharge: a prospective observational study
  5. Red cell distribution width in adults with acute ischaemic stroke compared across neurological severity categories for predicting functional status at three months: a prospective observational study
  6. Serum sodium concentration in adults with acute ischaemic stroke compared across neurological severity categories for predicting in-hospital complications and mortality: a prospective observational study
  7. Serum uric acid in adults with acute ischaemic stroke compared across infarct severity categories for predicting functional outcome at discharge: a prospective observational study
  8. Admission haemoglobin in adults with acute ischaemic stroke compared across anaemia categories for predicting functional status at three months: a prospective observational study
  9. Platelet to lymphocyte ratio in adults with acute ischaemic stroke compared across National Institutes of Health Stroke Scale categories for predicting in-hospital neurological deterioration: a prospective observational study
  10. Mean platelet volume in adults with acute ischaemic stroke compared across infarct severity categories for predicting functional outcome at discharge: a prospective observational study
  11. Triglyceride to high-density lipoprotein cholesterol ratio in adults with acute ischaemic stroke compared across infarct subtypes for identifying large-artery atherosclerotic disease: a cross-sectional analytical study
  12. Carotid intima-media thickness in adults with anterior circulation ischaemic stroke compared across vascular risk categories for identifying extracranial atherosclerotic burden: a cross-sectional analytical study
  13. Carotid stenosis on Doppler ultrasonography in adults with anterior circulation ischaemic stroke compared across recurrent and first-ever stroke groups for identifying recurrence risk factors: a comparative cross-sectional study
  14. Corrected QT interval in adults with acute ischaemic stroke compared across infarct locations for identifying cardiac repolarisation abnormalities during admission: a cross-sectional analytical study
  15. Electrocardiographic atrial fibrillation in adults with acute ischaemic stroke compared across age and infarct pattern categories for identifying cardioembolic stroke phenotype: a cross-sectional analytical study
  16. Presentation delay in adults with acute ischaemic stroke compared across referral pathways for determining eligibility for time-sensitive reperfusion treatment at hospital arrival: a cross-sectional analytical study
  17. Prehospital symptom recognition in adults with acute ischaemic stroke compared across educational categories for determining presentation within the therapeutic window: a cross-sectional analytical study
  18. Swallowing assessment score in adults with acute ischaemic stroke compared with clinically diagnosed aspiration for predicting pneumonia during hospitalisation: a diagnostic accuracy study
  19. Modified Rankin Scale score at discharge in adults with acute ischaemic stroke compared across admission National Institutes of Health Stroke Scale categories for predicting three-month disability: a prospective observational study
  20. Barthel Index score in adults surviving acute ischaemic stroke compared across infarct locations for determining functional recovery at three months: a prospective observational study

Intracerebral Haemorrhage and Other Cerebrovascular Disorders

  1. Intracerebral Haemorrhage Score in adults with spontaneous intracerebral haemorrhage compared with observed in-hospital mortality for validating short-term prognosis: a prospective validation study
  2. Glasgow Coma Scale score in adults with spontaneous intracerebral haemorrhage compared across computed tomography haematoma volumes for predicting in-hospital mortality: a prospective observational study
  3. Admission systolic blood pressure in adults with spontaneous intracerebral haemorrhage compared across haematoma volume categories for predicting neurological deterioration during hospitalisation: a prospective observational study
  4. Serum sodium concentration in adults with intracerebral haemorrhage compared across neurological severity categories for predicting in-hospital mortality: a prospective observational study
  5. Admission blood glucose in adults with spontaneous intracerebral haemorrhage compared across haematoma volumes for predicting functional outcome at discharge: a prospective observational study
  6. Neutrophil to lymphocyte ratio in adults with intracerebral haemorrhage compared across Intracerebral Haemorrhage Score categories for predicting in-hospital mortality: a prospective observational study
  7. Platelet count in adults with spontaneous intracerebral haemorrhage compared across haematoma volume categories for predicting haematoma expansion documented during routine care: a prospective observational study
  8. International normalized ratio in adults with anticoagulant-associated intracerebral haemorrhage compared across haematoma severity categories for predicting in-hospital mortality: a prospective observational study
  9. Haematoma volume on computed tomography in adults with spontaneous intracerebral haemorrhage compared across Glasgow Coma Scale categories for predicting functional status at discharge: a prospective observational study
  10. Intraventricular extension on computed tomography in adults with intracerebral haemorrhage compared with haemorrhage without ventricular extension for predicting in-hospital mortality: a comparative prospective study
  11. Haemorrhage location on computed tomography in adults with spontaneous intracerebral haemorrhage compared across hypertension status categories for identifying clinical presentation patterns: a cross-sectional analytical study
  12. Serum creatinine concentration in adults with intracerebral haemorrhage compared across kidney function categories for predicting in-hospital mortality: a prospective observational study
  13. Corrected QT interval in adults with spontaneous intracerebral haemorrhage compared across haemorrhage locations for identifying neurocardiac electrical abnormalities at admission: a cross-sectional analytical study
  14. Electrocardiographic abnormalities in adults with subarachnoid haemorrhage diagnosed during routine care compared across neurological severity categories for predicting in-hospital complications: a prospective observational study
  15. Serum sodium concentration in adults with subarachnoid haemorrhage compared across clinical severity categories for predicting neurological deterioration during hospitalisation: a prospective observational study
  16. Presentation delay in adults with intracerebral haemorrhage compared across urban and rural referral pathways for determining neurological severity at hospital arrival: a cross-sectional analytical study
  17. Modified Rankin Scale score at discharge in adults with intracerebral haemorrhage compared across admission Intracerebral Haemorrhage Score categories for predicting three-month disability: a prospective observational study
  18. Blood pressure treatment adherence before stroke in adults with hypertensive intracerebral haemorrhage compared across haemorrhage severity categories for identifying preventable risk factors: a cross-sectional analytical study
  19. Cerebral venous thrombosis score based on presenting clinical features in adults with computed tomography or magnetic resonance confirmed disease compared with functional outcome at discharge: a prospective observational study
  20. D-dimer concentration in adults with clinically suspected cerebral venous thrombosis compared with routine neuroimaging diagnosis for detecting venous thrombosis at presentation: a diagnostic accuracy study

Seizures and Epilepsy

  1. Serum sodium concentration in adults presenting with first-onset seizure compared across acute symptomatic and unprovoked seizure categories for identifying metabolic precipitants at presentation: a cross-sectional analytical study
  2. Serum calcium concentration in adults presenting with new-onset seizure compared across seizure types for detecting hypocalcaemia as an acute precipitant: a cross-sectional analytical study
  3. Serum magnesium concentration in adults with first-onset generalised seizure compared across recurrent and single seizure groups for detecting electrolyte abnormalities at presentation: a cross-sectional analytical study
  4. Random plasma glucose in adults presenting with new-onset seizure compared across diabetic and non-diabetic groups for identifying glycaemic precipitants at presentation: a cross-sectional analytical study
  5. Computed tomography brain abnormalities in adults with first-onset seizure compared across focal and generalised presentations for identifying structural causes: a cross-sectional analytical study
  6. Electroencephalographic abnormalities in adults with first unprovoked seizure compared across computed tomography findings for predicting seizure recurrence within three months: a prospective observational study
  7. Seizure duration in adults with convulsive status epilepticus compared across aetiological categories for predicting in-hospital mortality: a prospective observational study
  8. Status Epilepticus Severity Score in adults with convulsive status epilepticus compared with observed in-hospital mortality for validating short-term prognosis: a prospective validation study
  9. Glasgow Coma Scale score after seizure control in adults with status epilepticus compared across underlying causes for predicting mechanical ventilation requirement: a prospective observational study
  10. Serum lactate where routinely measured in adults with convulsive seizures compared between epileptic seizures and syncope for distinguishing the two presentations: a diagnostic accuracy study
  11. Creatine kinase concentration in adults after generalised tonic-clonic seizure compared with patients presenting with syncope for differentiating seizure from transient loss of consciousness: a diagnostic accuracy study
  12. Antiseizure medication adherence score in adults with epilepsy compared across breakthrough seizure categories for predicting seizure recurrence at three months: a prospective observational study
  13. Antiseizure medication count in adults with epilepsy compared across seizure control categories for identifying drug-resistant epilepsy phenotype at enrolment: a cross-sectional analytical study
  14. Serum sodium concentration in adults receiving carbamazepine for epilepsy compared across treatment duration categories for detecting treatment-associated hyponatraemia: a cross-sectional analytical study
  15. Liver enzyme abnormalities in adults receiving long-term valproate therapy compared across treatment duration categories for detecting treatment-associated hepatic biochemical abnormalities: a cross-sectional analytical study
  16. Body mass index in adults receiving long-term valproate therapy compared across treatment duration categories for identifying treatment-associated weight gain at enrolment: a cross-sectional analytical study
  17. Vitamin D concentration in adults receiving long-term antiseizure medication compared across enzyme-inducing and non-enzyme-inducing regimens for detecting deficiency: a comparative cross-sectional study
  18. Sleep quality score in adults with epilepsy compared across seizure control categories for identifying poor sleep associated with breakthrough seizures: a cross-sectional analytical study
  19. Depression screening score in adults with epilepsy compared across seizure frequency categories for identifying depressive symptoms at enrolment: a cross-sectional analytical study
  20. Driving and occupational restriction adherence in adults with epilepsy compared across educational categories for determining safety-practice compliance at enrolment: a cross-sectional analytical study

Central Nervous System Infections

  1. Cerebrospinal fluid glucose concentration in adults with acute meningitis compared across microbiologically confirmed bacterial and tuberculous categories for differentiating aetiology at presentation: a comparative cross-sectional study
  2. Cerebrospinal fluid protein concentration in adults with meningitis compared across bacterial, tuberculous and viral diagnostic categories for identifying aetiological patterns: a cross-sectional analytical study
  3. Cerebrospinal fluid leucocyte count in adults with acute meningitis compared across microbiological diagnoses for distinguishing bacterial from non-bacterial infection: a diagnostic accuracy study
  4. Cerebrospinal fluid adenosine deaminase where routinely available in adults with suspected tuberculous meningitis compared with microbiological confirmation for detecting tuberculous meningitis: a diagnostic accuracy study
  5. Modified British Medical Research Council stage in adults with tuberculous meningitis compared across cerebrospinal fluid findings for predicting in-hospital mortality: a prospective observational study
  6. Admission serum sodium in adults with tuberculous meningitis compared across neurological severity stages for predicting in-hospital mortality: a prospective observational study
  7. Hyponatraemia in adults with tuberculous meningitis compared across clinical volume status categories for identifying neurological severity and hospital outcome: a prospective observational study
  8. Glasgow Coma Scale score in adults with acute bacterial meningitis compared across cerebrospinal fluid abnormalities for predicting in-hospital mortality: a prospective observational study
  9. Neutrophil to lymphocyte ratio in adults with acute meningitis compared across bacterial and non-bacterial diagnoses for predicting in-hospital complications: a prospective observational study
  10. Platelet count in adults with acute encephalitis syndrome compared across confirmed infectious causes for predicting in-hospital mortality: a prospective observational study
  11. Serum sodium concentration in adults with acute encephalitis syndrome compared across neurological severity categories for predicting mechanical ventilation requirement: a prospective observational study
  12. Glasgow Coma Scale score in adults with acute encephalitis syndrome compared across neuroimaging abnormalities for predicting functional status at discharge: a prospective observational study
  13. Cerebrospinal fluid cell count in adults with cryptococcal meningitis and human immunodeficiency virus infection compared across neurological severity categories for predicting in-hospital mortality: a prospective observational study
  14. CD4 lymphocyte count in adults with human immunodeficiency virus infection and central nervous system opportunistic infections compared across diagnostic categories for predicting in-hospital mortality: a prospective observational study
  15. Serum sodium concentration in adults with cryptococcal meningitis compared across intracranial pressure symptom categories for predicting poor outcome at discharge: a prospective observational study
  16. Presentation delay in adults with tuberculous meningitis compared across referral pathways for determining neurological stage at hospital admission: a cross-sectional analytical study
  17. Computed tomography abnormalities in adults with tuberculous meningitis compared across clinical stages for predicting functional status at discharge: a prospective observational study
  18. Cerebrospinal fluid chloride concentration in adults with suspected tuberculous meningitis compared across microbiologically confirmed and non-confirmed cases for determining diagnostic usefulness: a diagnostic accuracy study
  19. Seizure occurrence in adults with central nervous system infection compared across bacterial, tuberculous and viral categories for predicting in-hospital complications: a prospective observational study
  20. Modified Rankin Scale score at discharge in adults treated for central nervous system infection compared across admission neurological severity categories for predicting three-month disability: a prospective observational study

Headache and Primary Headache Disorders

  1. Headache Impact Test score in adults with migraine compared across headache frequency categories for determining functional disability at enrolment: a cross-sectional analytical study
  2. Migraine Disability Assessment score in adults with migraine compared across attack frequency categories for identifying severe headache-related disability at enrolment: a cross-sectional analytical study
  3. Sleep quality score in adults with migraine compared across episodic and chronic migraine categories for identifying poor sleep at enrolment: a comparative cross-sectional study
  4. Depression screening score in adults with migraine compared across headache disability categories for identifying depressive symptoms at enrolment: a cross-sectional analytical study
  5. Anxiety screening score in adults with migraine compared across attack frequency categories for identifying anxiety symptoms at enrolment: a cross-sectional analytical study
  6. Body mass index in adults with migraine compared across episodic and chronic migraine categories for identifying obesity associated with headache chronification: a cross-sectional analytical study
  7. Caffeine intake in adults with recurrent migraine compared across headache frequency categories for identifying lifestyle factors associated with frequent attacks: a cross-sectional analytical study
  8. Analgesic use frequency in adults with chronic headache compared with International Classification of Headache Disorders criteria for detecting medication-overuse headache: a diagnostic accuracy study
  9. Headache red-flag features in adults presenting to medical emergency services compared with computed tomography findings obtained during routine care for detecting secondary headache: a diagnostic accuracy study
  10. Systolic blood pressure in adults presenting with acute severe headache compared across primary and secondary headache diagnoses for identifying hypertensive presentations: a comparative cross-sectional study
  11. Fundus examination findings in adults with headache and visual symptoms compared with neuroimaging diagnosis for detecting raised intracranial pressure: a diagnostic accuracy study
  12. Body mass index in women with idiopathic intracranial hypertension diagnosed during routine care compared across papilloedema severity categories for identifying obesity burden: a cross-sectional analytical study
  13. Opening cerebrospinal fluid pressure where clinically measured in adults with suspected idiopathic intracranial hypertension compared across papilloedema grades for determining disease severity: a cross-sectional analytical study
  14. Headache duration in adults with cerebral venous thrombosis compared across neurological complication categories for identifying delayed presentation at admission: a cross-sectional analytical study
  15. Migraine aura characteristics in adults with migraine compared across headache frequency categories for identifying greater disability at enrolment: a cross-sectional analytical study
  16. Trigger burden score in adults with migraine compared across episodic and chronic migraine categories for identifying modifiable precipitating factors: a cross-sectional analytical study
  17. Menstrual association in women with migraine compared across aura categories for determining attack frequency and headache-related disability: a cross-sectional analytical study
  18. Treatment adherence score in adults receiving migraine prophylaxis compared across headache-frequency reduction categories for predicting response at twelve weeks: a prospective observational study
  19. Headache diary frequency in adults receiving routine migraine prophylaxis compared with baseline Migraine Disability Assessment score for predicting disability improvement at twelve weeks: a prospective observational study
  20. Emergency department revisit rate in adults presenting with primary headache compared across initial headache severity categories for predicting repeat presentation within three months: a prospective observational study

Movement Disorders and Parkinsonism

  1. Movement Disorder Society Unified Parkinson's Disease Rating Scale motor score in adults with Parkinson disease compared across disease duration categories for determining motor severity: a cross-sectional analytical study
  2. Hoehn and Yahr stage in adults with Parkinson disease compared across disease duration categories for determining functional disability at enrolment: a cross-sectional analytical study
  3. Timed Up and Go test in adults with Parkinson disease compared across fall-history categories for identifying high fall risk at enrolment: a diagnostic accuracy study
  4. Five Times Sit to Stand test in adults with Parkinson disease compared with Timed Up and Go performance for identifying mobility impairment at enrolment: a comparative cross-sectional study
  5. Orthostatic blood pressure fall in adults with Parkinson disease compared across disease severity stages for detecting autonomic dysfunction at enrolment: a cross-sectional analytical study
  6. Constipation severity score in adults with Parkinson disease compared across disease duration categories for determining autonomic symptom burden at enrolment: a cross-sectional analytical study
  7. Sleep quality score in adults with Parkinson disease compared across motor severity categories for identifying poor sleep at enrolment: a cross-sectional analytical study
  8. Depression screening score in adults with Parkinson disease compared across functional stages for identifying depressive symptoms at enrolment: a cross-sectional analytical study
  9. Cognitive screening score in adults with Parkinson disease compared across disease duration categories for detecting mild cognitive impairment at enrolment: a cross-sectional analytical study
  10. Levodopa treatment duration in adults with Parkinson disease compared across dyskinesia status categories for identifying treatment-related motor complications: a cross-sectional analytical study
  11. Daily levodopa dose in adults with Parkinson disease compared across wearing-off symptom categories for identifying motor fluctuations at enrolment: a cross-sectional analytical study
  12. Medication adherence score in adults with Parkinson disease compared across motor control categories for predicting functional status at twelve weeks: a prospective observational study
  13. Fall frequency in adults with Parkinson disease compared across postural instability categories for predicting recurrent falls within three months: a prospective observational study
  14. Freezing of gait questionnaire score in adults with Parkinson disease compared across disease stages for identifying recurrent fall risk at enrolment: a cross-sectional analytical study
  15. Resting tremor severity in adults with Parkinson disease compared across dominant motor phenotypes for determining functional impairment at enrolment: a cross-sectional analytical study
  16. Serum vitamin B12 concentration in adults receiving long-term levodopa therapy compared across treatment duration categories for detecting biochemical deficiency at enrolment: a cross-sectional analytical study
  17. Serum homocysteine where routinely available in adults receiving long-term levodopa compared across vitamin B12 status categories for identifying biochemical abnormalities: a cross-sectional analytical study
  18. Handwriting size in adults with Parkinson disease compared across motor severity stages for identifying micrographia-related functional impairment at enrolment: a cross-sectional analytical study
  19. Essential tremor severity score in adults with clinically diagnosed essential tremor compared across disease duration categories for determining functional disability: a cross-sectional analytical study
  20. Thyroid function tests in adults presenting with new-onset tremor compared across hyperthyroid and euthyroid categories for detecting endocrine causes at enrolment: a cross-sectional analytical study

Peripheral Neuropathy and Radiculopathy

  1. Michigan Neuropathy Screening Instrument score in adults with type 2 diabetes mellitus compared with monofilament testing for detecting distal symmetrical peripheral neuropathy: a diagnostic accuracy study
  2. Monofilament sensory loss in adults with type 2 diabetes mellitus compared across glycated haemoglobin categories for identifying peripheral neuropathy at enrolment: a cross-sectional analytical study
  3. Vibration perception using tuning fork in adults with diabetes mellitus compared with monofilament testing for detecting clinically significant peripheral neuropathy: a comparative diagnostic study
  4. Neuropathy symptom score in adults with type 2 diabetes mellitus compared across diabetes duration categories for determining peripheral neuropathy severity at enrolment: a cross-sectional analytical study
  5. Ankle reflex loss in adults with diabetic neuropathy compared across sensory deficit categories for identifying advanced peripheral nerve involvement at enrolment: a cross-sectional analytical study
  6. Glycated haemoglobin concentration in adults with diabetic peripheral neuropathy compared across neuropathy severity categories for identifying poor glycaemic control: a cross-sectional analytical study
  7. Serum vitamin B12 concentration in adults with peripheral neuropathy receiving long-term metformin compared across treatment duration categories for detecting deficiency at enrolment: a cross-sectional analytical study
  8. Serum vitamin B12 concentration in adults with unexplained distal sensory neuropathy compared across vegetarian and mixed dietary patterns for detecting deficiency at enrolment: a cross-sectional analytical study
  9. Thyroid-stimulating hormone concentration in adults with unexplained peripheral neuropathy compared across neuropathy severity categories for detecting previously unrecognised hypothyroidism: a cross-sectional analytical study
  10. Serum creatinine concentration in adults with chronic kidney disease and peripheral neuropathic symptoms compared across kidney function stages for identifying uraemic neuropathy phenotype: a cross-sectional analytical study
  11. Neuropathy Disability Score in adults with chronic kidney disease compared across estimated glomerular filtration rate categories for determining peripheral neuropathy burden: a cross-sectional analytical study
  12. Alcohol exposure duration in adults with distal symmetrical peripheral neuropathy compared across neuropathy severity categories for identifying alcohol-related nerve dysfunction: a cross-sectional analytical study
  13. Human immunodeficiency virus infection duration in adults with peripheral neuropathy compared across antiretroviral treatment categories for determining neuropathy burden at enrolment: a cross-sectional analytical study
  14. Tuberculosis treatment exposure in adults with new peripheral neuropathy compared across isoniazid and non-isoniazid treatment histories for identifying treatment-associated neuropathy: a comparative cross-sectional study
  15. Pyridoxine adherence in adults receiving isoniazid-containing tuberculosis therapy compared across neuropathic symptom categories for identifying potentially preventable peripheral neuropathy: a cross-sectional analytical study
  16. Straight leg raising test in adults with suspected lumbosacral radiculopathy compared with clinically indicated neuroimaging findings for detecting nerve root compression: a diagnostic accuracy study
  17. Motor weakness pattern in adults with lumbosacral radiculopathy compared across computed tomography or magnetic resonance imaging levels obtained during routine care for determining clinical concordance: a cross-sectional analytical study
  18. Pain severity score in adults with lumbosacral radiculopathy compared across neurological deficit categories for predicting functional limitation at enrolment: a cross-sectional analytical study
  19. Oswestry Disability Index score in adults with lumbar radiculopathy compared across pain severity categories for determining functional impairment at enrolment: a cross-sectional analytical study
  20. Neuropathic Pain Scale score in adults with peripheral neuropathy compared across underlying aetiological categories for determining pain burden at enrolment: a cross-sectional analytical study

Neuromuscular Disorders and Myopathies

  1. Creatine kinase concentration in adults presenting with proximal muscle weakness compared across inflammatory, endocrine and drug-related causes for identifying myopathic disorders at enrolment: a cross-sectional analytical study
  2. Thyroid-stimulating hormone concentration in adults with unexplained proximal muscle weakness compared across creatine kinase categories for detecting hypothyroid myopathy: a cross-sectional analytical study
  3. Serum potassium concentration in adults presenting with acute flaccid weakness compared across clinical diagnostic categories for detecting hypokalaemic paralysis: a cross-sectional analytical study
  4. Thyroid function tests in adults with hypokalaemic paralysis compared across recurrent and first-episode groups for detecting thyrotoxic periodic paralysis: a cross-sectional analytical study
  5. Admission potassium concentration in adults with hypokalaemic paralysis compared across weakness severity categories for predicting time to motor recovery: a prospective observational study
  6. Serum phosphate concentration in adults with acute muscle weakness compared across nutritional and systemic illness categories for detecting hypophosphataemic weakness: a cross-sectional analytical study
  7. Creatine kinase level in adults receiving statin therapy with muscle symptoms compared across statin exposure categories for identifying statin-associated myopathy: a cross-sectional analytical study
  8. Vitamin D concentration in adults with chronic proximal muscle weakness compared across muscle strength categories for identifying vitamin D deficiency at enrolment: a cross-sectional analytical study
  9. Medical Research Council sum score in adults with Guillain-Barré syndrome compared across electrophysiological subtypes obtained during routine care for predicting ventilation requirement: a prospective observational study
  10. Erasmus Guillain-Barré Respiratory Insufficiency Score in adults with Guillain-Barré syndrome compared with observed mechanical ventilation requirement for validating respiratory risk prediction: a prospective validation study
  11. Hughes Disability Scale score in adults with Guillain-Barré syndrome compared across electrophysiological subtypes for predicting functional status at discharge: a prospective observational study
  12. Serum sodium concentration in adults with Guillain-Barré syndrome compared across weakness severity categories for predicting in-hospital complications: a prospective observational study
  13. Autonomic dysfunction signs in adults with Guillain-Barré syndrome compared across Medical Research Council sum score categories for predicting intensive care requirement: a prospective observational study
  14. Single breath count in adults with acute neuromuscular weakness compared with clinically measured respiratory function for detecting impending respiratory failure: a diagnostic accuracy study
  15. Neck flexor weakness in adults with acute neuromuscular disease compared with mechanical ventilation requirement for identifying respiratory deterioration during hospitalisation: a prospective observational study
  16. Myasthenia Gravis Foundation of America clinical class in adults with myasthenia gravis compared across bulbar symptom categories for predicting hospitalisation requirement: a cross-sectional analytical study
  17. Single breath count in adults with myasthenia gravis exacerbation compared with clinically measured respiratory function for detecting impending myasthenic crisis: a diagnostic accuracy study
  18. Thyroid function abnormalities in adults with myasthenia gravis compared across generalised and ocular disease categories for detecting autoimmune thyroid comorbidity: a cross-sectional analytical study
  19. Medication adherence score in adults with myasthenia gravis compared across exacerbation frequency categories for predicting symptomatic worsening within three months: a prospective observational study
  20. Creatine kinase concentration in adults with inflammatory myopathy diagnosed during routine care compared across muscle weakness grades for determining biochemical disease severity: a cross-sectional analytical study

Cognitive Disorders, Delirium and Geriatric Neurology

  1. Montreal Cognitive Assessment score in older adults with subjective cognitive complaints compared with Mini-Mental State Examination score for detecting cognitive impairment at enrolment: a comparative diagnostic study
  2. Mini-Mental State Examination score in older adults with cognitive complaints compared across educational categories for determining education-related variation in cognitive screening: a cross-sectional analytical study
  3. Clinical Dementia Rating score in older adults with diagnosed dementia compared across functional dependency categories for determining disease severity at enrolment: a cross-sectional analytical study
  4. Vitamin B12 concentration in older adults with cognitive impairment compared with cognitively normal older adults for detecting biochemical deficiency at enrolment: a case-control study
  5. Thyroid-stimulating hormone concentration in older adults with cognitive impairment compared with cognitively normal controls for detecting thyroid dysfunction at enrolment: a case-control study
  6. Serum sodium concentration in older adults with acute confusion compared between delirium and non-delirium groups for detecting electrolyte-associated cognitive dysfunction: a comparative cross-sectional study
  7. Confusion Assessment Method score in older medical inpatients compared with specialist clinical diagnosis for detecting delirium during hospitalisation: a diagnostic accuracy study
  8. Delirium severity score in older medical inpatients compared across infection and non-infection categories for predicting in-hospital mortality: a prospective observational study
  9. Clinical Frailty Scale score in older adults with delirium compared across delirium severity categories for predicting length of hospital stay: a prospective observational study
  10. Polypharmacy burden in older adults admitted with delirium compared with age-matched inpatients without delirium for identifying medication-related risk factors: a case-control study
  11. Anticholinergic medication burden in older adults with acute confusion compared between delirium and non-delirium groups for identifying potentially modifiable risk factors: a case-control study
  12. Sleep quality before admission in older adults with delirium compared with non-delirious controls for identifying predisposing factors at enrolment: a case-control study
  13. Hearing impairment in older medical inpatients compared between those with and without delirium for identifying sensory risk factors during hospitalisation: a case-control study
  14. Visual impairment in older adults admitted to medical wards compared across delirium status categories for identifying sensory contributors to acute confusion: a comparative cross-sectional study
  15. Nutritional status score in older adults with cognitive impairment compared across dementia severity categories for identifying undernutrition at enrolment: a cross-sectional analytical study
  16. Geriatric Depression Scale score in older adults with cognitive complaints compared across cognitive screening categories for identifying depressive pseudodementia phenotype: a cross-sectional analytical study
  17. Timed Up and Go test in older adults with cognitive impairment compared across fall-history categories for identifying recurrent fall risk at enrolment: a diagnostic accuracy study
  18. Orthostatic blood pressure fall in older adults with recurrent falls compared with older adults without falls for identifying autonomic contributors at enrolment: a case-control study
  19. Cognitive screening score in older adults with previous stroke compared across functional disability categories for identifying post-stroke cognitive impairment at three months: a prospective observational study
  20. Medication adherence in older adults with dementia receiving chronic medical therapy compared across caregiver-support categories for predicting treatment adherence at three months: a prospective observational study

Neurological Manifestations of Systemic and Metabolic Diseases

  1. Serum sodium concentration in adults with hepatic encephalopathy compared across West Haven grades for predicting in-hospital mortality: a prospective observational study
  2. Serum ammonia concentration where routinely measured in adults with hepatic encephalopathy compared across West Haven grades for predicting neurological recovery at discharge: a prospective observational study
  3. Glasgow Coma Scale score in adults with hepatic encephalopathy compared across liver disease severity categories for predicting in-hospital mortality: a prospective observational study
  4. Serum sodium concentration in adults with uraemic encephalopathy compared across estimated glomerular filtration rate categories for predicting dialysis requirement: a prospective observational study
  5. Blood urea concentration in adults with uraemic encephalopathy compared across neurological severity categories for predicting recovery after routine dialysis: a prospective observational study
  6. Random plasma glucose in adults presenting with altered sensorium compared across hypoglycaemic and non-hypoglycaemic causes for identifying metabolic encephalopathy at admission: a cross-sectional analytical study
  7. Duration of hypoglycaemia symptoms in adults with severe hypoglycaemia compared across neurological deficit categories for predicting recovery at discharge: a prospective observational study
  8. Corrected serum sodium in adults with hyperglycaemic crisis and altered sensorium compared across measured sodium categories for predicting neurological recovery during hospitalisation: a prospective observational study
  9. Serum calcium concentration in adults presenting with seizures or altered sensorium compared across clinical diagnostic categories for detecting hypocalcaemic neurological manifestations: a cross-sectional analytical study
  10. Thyroid-stimulating hormone concentration in adults with unexplained cognitive slowing compared with euthyroid controls for identifying hypothyroid neurological manifestations at enrolment: a case-control study
  11. Neurological symptom burden in adults with vitamin B12 deficiency compared across haemoglobin and mean corpuscular volume categories for identifying subclinical haematological disease: a cross-sectional analytical study
  12. CD4 lymphocyte count in adults with human immunodeficiency virus infection and neurological symptoms compared across opportunistic infection categories for predicting in-hospital mortality: a prospective observational study
  13. Neurological manifestations in adults with human immunodeficiency virus infection compared across immunosuppression categories for determining central and peripheral nervous system involvement: a cross-sectional analytical study
  14. Peripheral neuropathy symptoms in adults with chronic kidney disease compared across kidney function stages for determining uraemic neurological involvement at enrolment: a cross-sectional analytical study
  15. Encephalopathy occurrence in adults with sepsis compared across sequential organ failure assessment score categories for predicting in-hospital mortality: a prospective observational study
  16. Glasgow Coma Scale score in adults with sepsis-associated encephalopathy compared across organ dysfunction categories for predicting mechanical ventilation requirement: a prospective observational study
  17. Neurological complications in adults with severe dengue compared across platelet count categories for predicting functional status at discharge: a prospective observational study
  18. Neurological manifestations in adults with scrub typhus compared across organ dysfunction categories for predicting in-hospital mortality: a prospective observational study
  19. Neurological complications in adults with malaria compared across parasitaemia severity categories where routinely reported for predicting in-hospital mortality: a prospective observational study
  20. Acute kidney injury in adults with metabolic encephalopathy compared across neurological severity categories for predicting prolonged hospital stay and in-hospital mortality: a prospective observational study

Looking for premium Neurology thesis topics for your DM? Or the full medicine collection across all sections? Updated September 2026.

📌 Updated for 2026–2027 MD/DNB Medicine Neurology admissions

The page has been reviewed for practical feasibility, current neurological case definitions, realistic follow-up windows and investigations commonly available in medical colleges and teaching hospitals.

  • Most topics can be completed with structured neurological examination, validated bedside scales, routine blood tests, electrocardiography, cerebrospinal fluid analysis, electroencephalography and clinically indicated computed tomography or magnetic resonance imaging.
  • Research-only advanced neuroimaging, genetic panels, specialised biomarkers and invasive procedures are not required for the majority of projects.
  • Strong publication potential lies in stroke outcome prediction, seizure recurrence, neurological infections, functional recovery, cognitive screening, treatment adherence and diagnostic accuracy of practical bedside tools.
Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

  • Introduction / Synopsis
  • Research Question
  • Aim of the Study
  • Primary Objective
  • Secondary Objectives
  • Materials and Methods
  • Inclusion Criteria
  • Exclusion Criteria
  • Sample Size Calculation
  • Methodology
  • Statistical Analysis
  • Ethical Considerations
  • Review of Literature
  • References
  • Gantt Chart / Study Timeline
  • Patient Information Sheet
  • Consent Form
  • Data Collection Form

Already have your thesis title?

Generate the full neurology protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside neurology protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Neurology research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the neurology research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the neurology research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare a neurology research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A neurology IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning neurology research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the neurology research proposal is the document assessed at the start of it.

Kuwait — KIMS. A neurology study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the neurology proposal follows the same structure throughout.

Generate a neurology research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A neurology dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full neurology research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about a neurology PhD or MMed proposal →

🔥 Trending research areas in Neurology for 2026–27

  • Functional outcome after stroke: studies increasingly combine early neurological severity with disability at discharge and short follow-up, provided the scoring time points and treatment exposure are prespecified.
  • Bedside prediction and screening tools: NIHSS, ICH Score, Status Epilepticus Severity Score, single-breath count, Timed Up and Go and delirium screening tools support practical validation studies when an appropriate clinical reference standard is available.
  • Neurological effects of systemic disease: renal, hepatic, metabolic, infectious and endocrine disorders provide feasible studies because neurological manifestations can be linked to routinely measured biochemical abnormalities.
  • Patient-reported neurological burden: headache disability, sleep quality, depression, treatment adherence, falls and functional limitation are increasingly relevant because they capture outcomes not reflected by imaging or laboratory values alone.

Protocol and synopsis guidance

What a Neurology protocol must contain

Define the neurological syndrome before recruitment. The protocol should state the diagnostic criteria for stroke, seizure, epilepsy, meningitis, migraine, Parkinson disease, delirium, neuropathy or the chosen condition. A symptom such as weakness, headache or altered sensorium is not a diagnosis and should not be used as the sole case definition.

Fix the timing of every neurological scale. NIHSS, Glasgow Coma Scale, modified Rankin Scale, Barthel Index, cognitive tests and movement-disorder scores can change rapidly after treatment or during recovery. The protocol should specify whether scoring occurs at admission, after stabilisation, at discharge or at a defined follow-up visit.

Separate predictors from outcomes. Admission severity scores may be used as predictors, while discharge or follow-up disability scores may be outcomes. Using overlapping versions of the same construct on both sides of the analysis can create circular results unless the time points and clinical meaning are clearly separated.

State the reference standard for diagnostic studies. A bedside sign, serum marker or screening score should be compared with a defensible reference such as specialist diagnosis, electroencephalography, neuroimaging, microbiological confirmation, cerebrospinal fluid findings or electrophysiology, depending on the question.

Neurology synopsis versus Neurology protocol

The synopsis is the concise academic registration document. It usually contains the title, rationale, objectives, design, setting, eligibility criteria, principal variables, sample size, analysis plan and ethical safeguards required by the institution or university.

The protocol is the operational document. It should additionally define the diagnostic criteria, exact neurological scale version, assessor training, timing of scoring, imaging or electroencephalography criteria, treatment exposure, follow-up window, recurrence definition and how uncertain or mixed diagnoses will be handled.

Neurology requires particular attention to observer variation. NIHSS, mRS, GCS, cognitive screens and movement-disorder scales can differ between assessors. The protocol should state who performs the scoring, whether the assessor is trained or blinded where relevant, and whether one or several assessors will be used throughout the study.

Sample size and statistical analysis

Base the sample size on the primary objective. Prevalence studies need an expected proportion and precision; correlation studies need an anticipated correlation coefficient; comparative studies need an expected difference between groups; diagnostic studies require assumptions for sensitivity or specificity; and prospective outcome studies need an expected event rate.

Do not convert repeated attacks, admissions or follow-up visits into independent participants. If one patient contributes several seizures, migraine attacks, admissions or neurological assessments, the protocol should prespecify one analytical unit or use methods that recognise repeated observations.

Match the analysis to the scale. Some neurological scores are ordinal rather than truly continuous. Group comparisons, ordinal regression, logistic regression, correlation or repeated-measures methods should be chosen according to the scale and outcome. Diagnostic studies should report sensitivity, specificity and confidence intervals against the reference standard.

Plan important confounders before recruitment. Age, baseline neurological severity, treatment delay, reperfusion or antiseizure treatment, infection, metabolic disturbance, premorbid function and comorbidity can materially affect neurological outcomes. A small clinically justified set of confounders is preferable to indiscriminate testing of every recorded variable.

Frequently Asked Questions – Neurology Thesis Topics (2026–27)

1. How do I choose a feasible neurology thesis topic?

For the 2026–2027 academic year, the most feasible topics are those built around a common neurological presentation, a routinely available examination or investigation, one clearly defined primary outcome and a follow-up period that fits residency timelines. Before finalising the title, confirm the likely monthly case load, access to neuroimaging or electroencephalography where required, and whether repeat functional assessment can be completed reliably.

2. Which study designs are commonly accepted for a neurology thesis?

Cross-sectional, comparative cross-sectional, case-control, prospective observational, retrospective record-based, diagnostic accuracy, validation, correlation and clinical-audit designs are all suitable when they match the objective. A design should not be called cross-sectional if the primary outcome depends on recovery, recurrence, deterioration, treatment response or disability measured later.

3. What should I settle with my guide before registering the topic?

Settle the exact neurological case definition, primary outcome, severity scale, timing of assessment, imaging or laboratory reference standard, treatment exposure, follow-up duration, assessor training and main statistical comparison. If the study depends on magnetic resonance imaging, electroencephalography, electrophysiology or a specialised cognitive scale, confirm routine availability before registration.

4. Can I use retrospective neurology records if neurological scores are incomplete?

Yes, but feasibility should be checked before registration. Retrospective stroke, seizure or encephalopathy studies often fail because admission NIHSS, Glasgow Coma Scale, premorbid function, exact treatment timing or discharge disability is missing. Review a small sample of records first and define the minimum dataset required for inclusion rather than reconstructing scores from incomplete notes unless the reconstruction method is prespecified and defensible.

5. What is the difference between a neurology synopsis and a protocol?

The synopsis is the shorter academic registration document, whereas the protocol contains the detailed operating rules needed to conduct the study reproducibly. In neurology, these rules should include diagnostic criteria, scale versions, assessor training, assessment timing, imaging or electroencephalography definitions, treatment exposure, recurrence definitions and follow-up procedures.

6. What ethical issues should a neurology thesis address?

Prospective studies require informed consent. When stroke, encephalopathy, dementia, severe infection or postictal confusion temporarily impairs decision-making capacity, the protocol should define an approved surrogate-consent pathway and later participant consent when capacity returns where required. Paediatric studies require guardian consent and age-appropriate assent from about seven years where applicable. Record-based projects may seek an ethics-approved waiver of consent when risk is minimal and confidentiality is protected. Research should not add computed tomography, magnetic resonance imaging, contrast, lumbar puncture, electroencephalography or venepuncture solely to create data unless specifically justified and approved. Separate consent is required for identifiable photographs or video, and clinically important incidental neurological or imaging findings should have a named escalation route to the treating team.

7. How should neurological severity and outcome scales be timed and interpreted?

The protocol should assign each scale one role and one prespecified time point. For example, an admission NIHSS may represent initial stroke severity, while a discharge or three-month modified Rankin Scale may represent disability outcome. Using two overlapping scores measured at nearly the same time can produce a mathematically strong but clinically uninformative association. Cognitive scores should also account for education, language, sensory impairment and delirium, while seizure-frequency outcomes should state whether they come from patient report, caregiver report or documented events. The aim is to prevent the measurement tool itself from defining both the exposure and the outcome.

8. Can these topics be adapted for PhD or Gulf board research requirements?

Yes, but the scope and document type should be redesigned rather than simply lengthening an MD synopsis. A PhD proposal generally needs a broader conceptual framework, stronger originality and more extensive methodology. Gulf training pathways may require a board research project rather than an Indian-style dissertation; this includes programmes linked to SCFHS and the Saudi Board, the Arab Board of Health Specializations, and DHP, DHA, DOH and MOHAP-linked training programmes. The clinical question can often be adapted, but approval pathways, sample size, supervision and reporting requirements should be checked against the relevant programme.

9. When should I register my neurology thesis topic?

Registration should occur after the guide has confirmed case availability, the diagnostic definition, neurological scale, assessment timing, required investigations, follow-up window and analysis plan, while leaving enough time for ethics approval and recruitment. Topics dependent on rare neuromuscular disease, specialised electrophysiology or prolonged functional follow-up need an especially careful feasibility check before formal submission.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol
Don`t copy text!
Generate Thesis Protocol / Synopsis
×